Department of Oncology, China-Japan Friendship Hospital, Beijing, China.
Graduate School, Beijing University of Chinese Medicine, Beijing, China.
J Int Med Res. 2022 Sep;50(9):3000605221118505. doi: 10.1177/03000605221118505.
Primary neuroendocrine carcinoma of the breast (NECB) is a rare tumour with an incident rate of 0.3-0.5%. The most common metastatic sites of NECB are liver, bones, lung, pancreas, soft tissues and brain, while leptomeninges metastasis (LM) is reported rarely. This current case report describes a 50-year-old female patient with NECB and LM whose overall survival was 2 months. The report also presents the current literature regarding the knowledge of this unusual tumour and metastatic type. The current patient was diagnosed with NECB with right cerebellar metastasis, followed by LM. She underwent modified radical mastectomy of the left breast, left whole breast radiation therapy and incomplete adjuvant chemotherapy until the metastasis occurred. Whole-brain radiation therapy and a first-line salvage regimen of etoposide and cis-platinum were then undertaken. The patient died 2 months after their LM diagnosis. Primary NECB with LM is sporadic, devoid of effective treatment and associated with a poor prognosis. Consequently, it is vitally important to identify LM in order to achieve longer patient survival.
原发性乳腺神经内分泌癌(NECB)是一种罕见的肿瘤,发病率为 0.3-0.5%。NECB 最常见的转移部位是肝、骨、肺、胰腺、软组织和脑,脑膜转移(LM)则较为罕见。本病例报告描述了一例 50 岁女性 NECB 合并 LM 患者,其总生存期为 2 个月。报告还介绍了目前关于这种不常见肿瘤和转移类型的文献知识。目前的患者被诊断为右小脑转移的 NECB,随后发生 LM。她接受了左侧改良根治性乳房切除术、左侧全乳房放射治疗和不完全辅助化疗,直到转移发生。然后进行了全脑放射治疗和依托泊苷和顺铂的一线挽救方案。患者在 LM 诊断后 2 个月死亡。原发性 NECB 合并 LM 是散发性的,缺乏有效治疗,预后不良。因此,识别 LM 对于延长患者生存至关重要。